Literature DB >> 20227040

Tumor stroma-derived TGF-beta limits myc-driven lymphomagenesis via Suv39h1-dependent senescence.

Maurice Reimann1, Soyoung Lee, Christoph Loddenkemper, Jan R Dörr, Vedrana Tabor, Peter Aichele, Harald Stein, Bernd Dörken, Thomas Jenuwein, Clemens A Schmitt.   

Abstract

Activated RAS/BRAF oncogenes induce cellular senescence as a tumor-suppressive barrier in early cancer development, at least in part, via an oncogene-evoked DNA damage response (DDR). In contrast, Myc activation-although producing a DDR as well-is known to primarily elicit an apoptotic countermeasure. Using the Emu-myc transgenic mouse lymphoma model, we show here in vivo that apoptotic lymphoma cells activate macrophages to secrete transforming growth factor beta (TGF-beta) as a critical non-cell-autonomous inducer of cellular senescence. Accordingly, neutralization of TGF-beta action, like genetic inactivation of the senescence-related histone methyltransferase Suv39h1, significantly accelerates Myc-driven tumor development via cancellation of cellular senescence. These findings, recapitulated in human aggressive B cell lymphomas, demonstrate that tumor-prompted stroma-derived signals may limit tumorigenesis by feedback senescence induction. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20227040     DOI: 10.1016/j.ccr.2009.12.043

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  85 in total

Review 1.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm.

Authors:  Subhra K Biswas; Alberto Mantovani
Journal:  Nat Immunol       Date:  2010-09-20       Impact factor: 25.606

Review 2.  The essence of senescence.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Wolter J Mooi; Daniel S Peeper
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

Review 3.  Microenvironment abnormalities and lymphomagenesis: Immunological aspects.

Authors:  Joseph G Taylor; John G Gribben
Journal:  Semin Cancer Biol       Date:  2015-07-29       Impact factor: 15.707

Review 4.  The role of MIZ-1 in MYC-dependent tumorigenesis.

Authors:  Katrin E Wiese; Susanne Walz; Björn von Eyss; Elmar Wolf; Dimitris Athineos; Owen Sansom; Martin Eilers
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

5.  Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance.

Authors:  Zhongwei Cao; Bi-Sen Ding; Peipei Guo; Sharrell B Lee; Jason M Butler; Stephanie C Casey; Michael Simons; Wayne Tam; Dean W Felsher; Koji Shido; Arash Rafii; Joseph M Scandura; Shahin Rafii
Journal:  Cancer Cell       Date:  2014-03-17       Impact factor: 31.743

Review 6.  Cellular senescence: from growth arrest to immunogenic conversion.

Authors:  D G A Burton; R G A Faragher
Journal:  Age (Dordr)       Date:  2015-03-20

Review 7.  A drive in SUVs: From development to disease.

Authors:  Vinay Kumar Rao; Ananya Pal; Reshma Taneja
Journal:  Epigenetics       Date:  2017-01-20       Impact factor: 4.528

8.  PIM1 induces cellular senescence through phosphorylation of UHRF1 at Ser311.

Authors:  J Yang; K Liu; J Yang; B Jin; H Chen; X Zhan; Z Li; L Wang; X Shen; M Li; W Yu; Z Mao
Journal:  Oncogene       Date:  2017-04-10       Impact factor: 9.867

9.  Changing T-cell enigma: cancer killing or cancer control?

Authors:  Thomas Wieder; Heidi Braumüller; Ellen Brenner; Lars Zender; Martin Röcken
Journal:  Cell Cycle       Date:  2013-08-26       Impact factor: 4.534

10.  Cellular senescence predicts treatment outcome in metastasised colorectal cancer.

Authors:  A M Haugstetter; C Loddenkemper; D Lenze; J Gröne; C Standfuss; I Petersen; B Dörken; C A Schmitt
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.